Email Newsletters

MetroWest

🔒Movers & Shakers for Sept. 27, 2021

People are on the move at Adcare Hospital, ERA Key Spencer, Savers Bank, and more.

🔒Mini-cluster: Worcester is trying to carve out its own niche in biotech

Located adjacent to the Polar Park baseball stadium in Worcester, the planned Left Field Building is a $16-million symbol of the ambitious plans in the city for the life sciences as a catalyst for its ever-evolving development efforts.

🔒Revival: The independent bookstore industry is growing with a loyal customer base wanting to shop local

As people around the U.S. turned inward over the last year and a half, consumers appear to have found a respite from the onslaught of technology dependence: reading.

Framingham representative appointed to U.S. Department of Energy

President Joe Biden announced plans late Wednesday to nominate Rep. Maria Robinson of Framingham to join his administration in the U.S. Department of Energy.
ADVERTISEMENT

Marlborough land near industrial developments sells for $2.1M

A 24-acre parcel of land at 149 Hayes Memorial Drive on the Marlborough-Northborough border sold to Toronto realty company Oxford Properties Group for $2.1 million, according to the Middlesex South Registry of Deeds.

Swiss dermatology company partners with Framingham medical device firm

Galderma, the world’s largest independent dermatology company headquartered in Lausanne, Switzerland, announced Thursday a co-development and option-to-acquire agreement with Framingham-based medical device firm Sofregen Inc.

Rave’s new platform streamlines emergency communication

Framingham mobile alert tech company Rave Mobile Safety announced the new Rave Platform experience in a Tuesday press release.

Hologic’s global study reveals gaps in women’s healthcare

Hologic, a Marlborough-based medical technology company focused on women’s health, released findings from its first Hologic Global Women’s Health Index, according to a Tuesday press release.
ADVERTISEMENT

Boston Scientific cancer treatment shown to be effective in clinical trial

Marlborough medical device manufacturer Boston Scientific Corp. announced Monday a clinical trial for its TheraSphere cancer treatment successfully met both of its primary endpoints.

Akoya Biosciences welcomes GeneCentric founder to its board

Akoya Biosciences, a Marlborough bioscience company, has appointed Dr. Myla Lai-Goldman, who has worked extensively in diagnostics and is the chair and co-founder of GeneCentric Therapeutics Inc. of North Carolina, to its board of directors, according to a Wednesday announcement.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

December Flash Sale! Get 40% off new subscriptions from now until December 19th!

Close the CTA

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA